Literature DB >> 11087823

3' deletions cause aniridia by preventing PAX6 gene expression.

J D Lauderdale1, J S Wilensky, E R Oliver, D S Walton, T Glaser.   

Abstract

Aniridia is a panocular human eye malformation caused by heterozygous null mutations within PAX6, a paired-box transcription factor, or cytogenetic deletions of chromosome 11p13 that encompass PAX6. Chromosomal rearrangements also have been described that disrupt 11p13 but spare the PAX6 transcription unit in two families with aniridia. These presumably cause a loss of gene expression, by removing positive cis regulatory elements or juxtaposing negative DNA sequences. We report two submicroscopic de novo deletions of 11p13 that cause aniridia but are located >11 kb from the 3' end of PAX6. The clinical manifestations are indistinguishable from cases with chain-terminating mutations in the coding region. Using human x mouse retinoblastoma somatic cell hybrids, we show that PAX6 is transcribed only from the normal allele but not from the deleted chromosome 11 homolog. Our findings suggest that remote 3' regulatory elements are required for initiation of PAX6 expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11087823      PMCID: PMC17648          DOI: 10.1073/pnas.240398797

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

Review 1.  Looping versus linking: toward a model for long-distance gene activation.

Authors:  M Bulger; M Groudine
Journal:  Genes Dev       Date:  1999-10-01       Impact factor: 11.361

2.  A highly conserved lens transcriptional control element from the Pax-6 gene.

Authors:  S C Williams; C R Altmann; R L Chow; A Hemmati-Brivanlou; R A Lang
Journal:  Mech Dev       Date:  1998-05       Impact factor: 1.882

3.  An extensive 3' regulatory region controls expression of Bmp5 in specific anatomical structures of the mouse embryo.

Authors:  R J DiLeone; L B Russell; D M Kingsley
Journal:  Genetics       Date:  1998-01       Impact factor: 4.562

4.  A systematic approach for detecting high-frequency restriction fragment length polymorphisms using large genomic probes.

Authors:  J Feder; L Yen; E Wijsman; L Wang; L Wilkins; J Schroder; N Spurr; H Cann; M Blumenberg; L L Cavalli-Sforza
Journal:  Am J Hum Genet       Date:  1985-07       Impact factor: 11.025

5.  Pax6 is required for differentiation of glucagon-producing alpha-cells in mouse pancreas.

Authors:  L St-Onge; B Sosa-Pineda; K Chowdhury; A Mansouri; P Gruss
Journal:  Nature       Date:  1997-05-22       Impact factor: 49.962

6.  Truncation mutations in the transactivation region of PAX6 result in dominant-negative mutants.

Authors:  S Singh; H K Tang; J Y Lee; G F Saunders
Journal:  J Biol Chem       Date:  1998-08-21       Impact factor: 5.157

7.  Distinct cis-essential modules direct the time-space pattern of the Pax6 gene activity.

Authors:  B Kammandel; K Chowdhury; A Stoykova; S Aparicio; S Brenner; P Gruss
Journal:  Dev Biol       Date:  1999-01-01       Impact factor: 3.582

Review 8.  Position effect in human genetic disease.

Authors:  D J Kleinjan; V van Heyningen
Journal:  Hum Mol Genet       Date:  1998       Impact factor: 6.150

Review 9.  PAX6 mutations reviewed.

Authors:  J Prosser; V van Heyningen
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

10.  Regulation of Pax6 expression is conserved between mice and flies.

Authors:  P X Xu; X Zhang; S Heaney; A Yoon; A M Michelson; R L Maas
Journal:  Development       Date:  1999-01       Impact factor: 6.868

View more
  61 in total

1.  The ABCA4 gene in autosomal recessive cone-rod dystrophies.

Authors:  Dominique Ducroq; Jean-Michel Rozet; Sylvie Gerber; Isabelle Perrault; Dabienne Barbet; Sylvain Hanein; Selim Hakiki; Jean-Louis Dufier; Arnold Munnich; Christian Hamel; Josseline Kaplan
Journal:  Am J Hum Genet       Date:  2002-12       Impact factor: 11.025

2.  Mutation of the Pax6 gene causes impaired glucose-stimulated insulin secretion.

Authors:  A Kuroda; H Kaneto; Y Fujitani; H Watada; Y Nakatani; Y Kajimoto; M Matsuhisa; Y Yamasakai; M Fujiwara
Journal:  Diabetologia       Date:  2004-11-24       Impact factor: 10.122

Review 3.  Genetic and epigenetic mechanisms of gene regulation during lens development.

Authors:  Ales Cvekl; Melinda K Duncan
Journal:  Prog Retin Eye Res       Date:  2007-07-28       Impact factor: 21.198

Review 4.  Functional anatomy of distant-acting mammalian enhancers.

Authors:  D E Dickel; A Visel; L A Pennacchio
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-05-06       Impact factor: 6.237

Review 5.  Genetics of anterior segment dysgenesis disorders.

Authors:  Linda M Reis; Elena V Semina
Journal:  Curr Opin Ophthalmol       Date:  2011-09       Impact factor: 3.761

6.  Pax6 expressed in osteocytes inhibits canonical Wnt signaling.

Authors:  Ajita Jami; Jogeswar Gadi; Min Jung Lee; Eun Jin Kim; Mi Jeong Lee; Han-Sung Jung; Hong-Hee Kim; Sung-Kil Lim
Journal:  Mol Cells       Date:  2013-03-22       Impact factor: 5.034

7.  The functional role of the Meis/Prep-binding elements in Pax6 locus during pancreas and eye development.

Authors:  Christian Carbe; Kristina Hertzler-Schaefer; Xin Zhang
Journal:  Dev Biol       Date:  2012-01-03       Impact factor: 3.582

Review 8.  Signaling and Gene Regulatory Networks in Mammalian Lens Development.

Authors:  Ales Cvekl; Xin Zhang
Journal:  Trends Genet       Date:  2017-08-31       Impact factor: 11.639

Review 9.  Enhancer deregulation in cancer and other diseases.

Authors:  Hans-Martin Herz
Journal:  Bioessays       Date:  2016-08-29       Impact factor: 4.345

10.  A novel distal enhancer mediates cytokine induction of mouse RANKl gene expression.

Authors:  Kathleen A Bishop; Mark B Meyer; J Wesley Pike
Journal:  Mol Endocrinol       Date:  2009-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.